
ARPO P/E Ratio
P/E Ratio as of Jul 25, 2025: 13.00
Average12.87
Median12.93
Minimum12.00
Maximum13.67
13.00
Past Month+0.33 (2.60%)
The P/E ratio for ARPO is 13.00 as of Jul 25, 2025. This represents a increase of 940.00% compared to its 12-month average P/E ratio of 1.25. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Aerpio Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Aerpio Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Aerpio Pharmaceuticals Inc to industry peers.
Aerpio Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Aerpio Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Aerpio Pharmaceuticals Inc to industry peers.
ARPO P/E Ratio Insights
See Aerpio Pharmaceuticals Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ARPO
Order type
Buy in
Order amount
Est. shares
0 shares
ARPO P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $1.86 | 12.40 |
Jun 2, 2025 | $1.74 | 11.60 |
May 1, 2025 | $1.67 | -0.71 |
Apr 1, 2025 | $1.70 | -0.72 |
Mar 3, 2025 | $2.30 | -1.01 |
Feb 3, 2025 | $2.74 | -1.20 |
Jan 2, 2025 | $3.14 | -1.37 |
ARPO End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | 13.00 | -1,042.03% |
2024 | -1.38 | +60.47% |
2023 | -0.86 | -80.05% |
2022 | -4.31 | +126.84% |
2021 | -1.90 | -83.05% |
2020 | -11.21 | — |
FAQs About Aerpio Pharmaceuticals Inc (ARPO) P/E ratio
The latest P/E ratio of ARPO is 13.00, as of Jul 25, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Aerpio Pharmaceuticals Inc’s last 12-month average P/E ratio is 1.25, compared to its current P/E ratio of 13.00. This reflects a increase of 940.00%.
Aerpio Pharmaceuticals Inc’s current P/E ratio of 13.00 is higher than its last 12-month average P/E of 1.25. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Aerpio Pharmaceuticals Inc’s average P/E ratio over the last 3 years is -1.14. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Aerpio Pharmaceuticals Inc’s average P/E ratio over the last 5 years is -4.03. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.